検索結果は7件です。

Which has a higher risk for developing pancreatic cancer, autoimmune pancreatitis or ordinary chronic pancreatitis?

Ikeura　Tsukasa（The Third Department of Internal Medicine, Kansai Medical University, Japan）
Purpose：Ordinary chronic pancreatitis（CP）, such as alcoholic CP, is well established to have the increased risk for pancreatic cancer（PaC）, nevertheless an association between autoimmune pancre...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）

Challenge to early detection of pancreatic ductal adenocarcinoma focused on surveillance of Intraductal Papillary Mucinous Neoplasm（IPMN）of the Pancreas

Tamura　Koji（Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Japan）
　IPMN has been recognized as a potential clue to early detection of pancreatic cancer. However, there have been few studies regarding the surveillance period/interval of resected or observed IPMNs. We...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）

Etomidate with meperidine vs midazolam with meperidine for sedation during Enodscopic Retrograde Cholangiopancreaticogram（ERCP）

Cha　Byung Hyo（Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital, Korea）
Backgrounds：ERCP is an invasive and high quality procedure. The aim of this study is to compare the efficacy and adverse effect of etomidate with meperidine and midazolam with meperidine undergoing ER...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）

The role of gastrodeuodenal stent intervention in the treatment of pancreatic cancers

Sato　Takamitsu（Department of Gastroenterology, Aichi Cancer Center Hospital, Japan, Division of Gastroenterology, Yokohama City University Graduate School of Medicine, Japan）
Background and study aims：Some pancreatic cancers are complicated with malignant gastric outlet obstructions（GOOs）, and which often disturb the treatment course. Self-expandable metallic stents...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）

Predictors of failed stenting during Endoscopic Retrograde Cholangiopancreatography（ERCP）in malignant biliary obstruction

Chu　Michael V.（East Avenue Medical Center, Section of Gastroenteorlogy, Philippines）
INTRODUCTION
Malignant biliary obstruction secondary to Pancreatic head malignancy and Cholangiocarcinoma often results in obstructive jaundice. The primary role of ERCP is to provide relief of obs...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）

A retrospective analysis comparing the treatment outcomes of gemcitabine and S-1 combination therapy to gemcitabine and cisplatin combination therapy in patients with advanced biliary tract cancer

Sasaki　Takashi（Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Japan）
Background：Gemcitabine and cisplatin（GC）combination therapy became the standard of care for the treatment of advanced biliary cancer. In Japan, gemcitabine and S-1（GS）combination therapy...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）

Combination of human equilibrative nucleoside transporter 1 and thymidylate synthase expression could predict prognosis after surgery in the locally advanced cholangiocarcinoma patients treated with NAC with gemcitabine and S-1

Yabushita　Yasuhiro（Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Japan）
Background/purpose
　The aim of this study is to clarlify the relationship between the intratumoral expression of chemosensitivity related markers such as human equilibrative nucleoside transporter ...

第100回日本消化器病学会総会 ＞ Short Oral Presentations（Pancreaticobiliary disorders 1）